Social Media Influencers Driving Parallel Trade for Unapproved Weight-Loss Medication
An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Investigations also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.
After minutes of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, messages display dark colored parcels with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service stated it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious medical dangers”.
